Loading clinical trials...

GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT05992532

GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

The study of splenomegaly, and the follow-up of splenectomized patients, is one of the causes of referral of these patients to pediatric gastroenterology and oncohematology clinics, and adult internal...

Lead sponsor: Fundación Española de Hematología y Hemoterapía•23 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

FEHH SEHH, MD

CONTACT

91 319 19 98 sehh@sehh.es

Related studies

RECRUITINGPhase 3

A Gaucher Disease Gene Therapy Trial With FLT201

NCT07223944 · Gaucher Disease Type 1

RECRUITING

Longitudinal Study of Neurodegenerative Disorders

NCT03333200 · MLD, Krabbe Disease, and more

RECRUITING

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

RECRUITINGPhase 1/2

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

NCT05487599 · Gaucher Disease, Gaucher Disease, Type 1

RECRUITING

A Long-term Follow-up Study of Gaucher Disease

NCT03190837 · Gaucher Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment210

Start dateMay 2023

Last updatedFeb 11, 2026

Condition

Gaucher Disease Acid SphingoMyelinase Deficiency

Locations shown

Hospital Universitario de Álava

Vitoria-Gasteiz, Alava

Hospital Universitario Torrecárdenas

Almería, Almería

Hospital Son Espases

Palma de Mallorca, Balearic Islands

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Contacts

Sponsors

Related studies

A Gaucher Disease Gene Therapy Trial With FLT201

Longitudinal Study of Neurodegenerative Disorders

Institutional Registry of Rare Diseases

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

A Long-term Follow-up Study of Gaucher Disease

Trial snapshot

Condition

Locations shown

For caregivers